Anna Grigoryeva

PSG is a growth equity firm that partners with software and technology-enabled services companies to help them navigate transformational growth, capitalize on strategic opportunities and build strong teams. Having backed more than 140 companies and facilitated over 500 add-on acquisitions, PSG brings extensive investment experience, deep expertise in software and technology, and a firm commitment to collaborating with management teams. Founded in 2014, PSG operates out of offices in Boston, Kansas City, London, Madrid, Paris and Tel-Aviv. To learn more about PSG, visit www.psgequity.com. Disclaimer: https://bit.ly/3aMVMpW Visit http://bit.ly/39lIOA8 for a comprehensive list of all investments.

Our mission: Make healthcare accessible, convenient, and affordable for all by automating primary care from symptom to outcome. Our Medical Guidance Platform is a set of intelligent healthcare technologies that enables early symptom assessment and digital triage, and supports communication between physicians and patients. At the core of Infermedica’s technologies are its Medical Knowledge Base, Inference Engine and API gateway. The platform minimizes the inappropriate use of medical services, and improves patient navigation and user satisfaction. Symptom-checking features provided by Infermedica can be freely implemented on webpages, mobile apps, and patient portals via API or ready-to-use triage and intake modules. Patient safety is the main focus of physicians, engineers, and scientists working, side-by-side, at Infermedica. The algorithms use dynamic interview scenarios to predict the lists of possible conditions. They analyze common language and verify combinations of symptoms. Infermedica modules are certified Medical Devices in the EU and compliant with HIPAA and GDPR standards. We have been adeptly interweaving medical and technical expertise into our technologies since 2012, to support industry leaders such as Global Excel, Gothaer, Médis, Microsoft, and Sana Kliniken. Infermedica is now being used in more than 30 countries and 20 languages, and has completed more than 14 million successful health checks to date. To learn more about the company and its products, visit infermedica.com. Also check out Symptomate, our consumer-facing symptom checker. Available for free use at symptomate.com User data is processed by Infermedica in accordance with the terms of the service and the data protection laws – GDPR for branding, communication and networking etc. All information about processing of your data and your rights can be found in the Privacy Policy on Infermedica.com or via dpo@infermedica.com.

Minut is the intelligence layer for proactive property management. From short-term rentals and student housing to multifamily units and aparthotels, Minut helps operators to stay one step ahead of issues like smoking, noise, and mold. With real-time insights and proactive alerts, Minut is creating a new layer of infrastructure for shared spaces, giving teams the foresight to run smarter, safer, and more profitable properties.

Karma Ventures (karma.vc) is an early-stage venture capital firm, specialised in late seed and A round investments in Europe’s most promising tech startups. We back companies with strong ideas delivered with unique technology, customer traction and global ambition. karma.vc accompanies entrepreneurs in figuring out the path to growth in all aspects - commercial, strategic and technical.

Karma Ventures (karma.vc) is an early-stage venture capital firm, specialised in late seed and A round investments in Europe’s most promising tech startups. We back companies with strong ideas delivered with unique technology, customer traction and global ambition. karma.vc accompanies entrepreneurs in figuring out the path to growth in all aspects - commercial, strategic and technical.

PSG is a growth equity firm that partners with software and technology-enabled services companies to help them navigate transformational growth, capitalize on strategic opportunities and build strong teams. Having backed more than 140 companies and facilitated over 500 add-on acquisitions, PSG brings extensive investment experience, deep expertise in software and technology, and a firm commitment to collaborating with management teams. Founded in 2014, PSG operates out of offices in Boston, Kansas City, London, Madrid, Paris and Tel-Aviv. To learn more about PSG, visit www.psgequity.com. Disclaimer: https://bit.ly/3aMVMpW Visit http://bit.ly/39lIOA8 for a comprehensive list of all investments.

Our mission: Make healthcare accessible, convenient, and affordable for all by automating primary care from symptom to outcome. Our Medical Guidance Platform is a set of intelligent healthcare technologies that enables early symptom assessment and digital triage, and supports communication between physicians and patients. At the core of Infermedica’s technologies are its Medical Knowledge Base, Inference Engine and API gateway. The platform minimizes the inappropriate use of medical services, and improves patient navigation and user satisfaction. Symptom-checking features provided by Infermedica can be freely implemented on webpages, mobile apps, and patient portals via API or ready-to-use triage and intake modules. Patient safety is the main focus of physicians, engineers, and scientists working, side-by-side, at Infermedica. The algorithms use dynamic interview scenarios to predict the lists of possible conditions. They analyze common language and verify combinations of symptoms. Infermedica modules are certified Medical Devices in the EU and compliant with HIPAA and GDPR standards. We have been adeptly interweaving medical and technical expertise into our technologies since 2012, to support industry leaders such as Global Excel, Gothaer, Médis, Microsoft, and Sana Kliniken. Infermedica is now being used in more than 30 countries and 20 languages, and has completed more than 14 million successful health checks to date. To learn more about the company and its products, visit infermedica.com. Also check out Symptomate, our consumer-facing symptom checker. Available for free use at symptomate.com User data is processed by Infermedica in accordance with the terms of the service and the data protection laws – GDPR for branding, communication and networking etc. All information about processing of your data and your rights can be found in the Privacy Policy on Infermedica.com or via dpo@infermedica.com.

Minut is the intelligence layer for proactive property management. From short-term rentals and student housing to multifamily units and aparthotels, Minut helps operators to stay one step ahead of issues like smoking, noise, and mold. With real-time insights and proactive alerts, Minut is creating a new layer of infrastructure for shared spaces, giving teams the foresight to run smarter, safer, and more profitable properties.

Karma Ventures (karma.vc) is an early-stage venture capital firm, specialised in late seed and A round investments in Europe’s most promising tech startups. We back companies with strong ideas delivered with unique technology, customer traction and global ambition. karma.vc accompanies entrepreneurs in figuring out the path to growth in all aspects - commercial, strategic and technical.

Karma Ventures (karma.vc) is an early-stage venture capital firm, specialised in late seed and A round investments in Europe’s most promising tech startups. We back companies with strong ideas delivered with unique technology, customer traction and global ambition. karma.vc accompanies entrepreneurs in figuring out the path to growth in all aspects - commercial, strategic and technical.